Objectives: Although the majority of patients undergoing total knee arthroplasty (TKA) report substantial improvement in pain and function, a significant subset experience persistent postsurgical pain and dysfunction. Better understanding of the longitudinal postoperative course is needed, including the association between patient status following physical rehabilitation at 6-weeks post-TKA, to 6-months outcomes. This study aims to described the postoperative course of TKA and examine variables associated with change in pain and functioning between 6-weeks and 6-months post-TKA.
T otal knee arthroplasty (TKA) is a prevalent procedure for patients with advanced osteoarthritis (OA) of the knee. As of 2010, ∼2.5 million Americans underwent TKA. 1 As a result of increased prevalence of obesity and increased acceptance of surgical safety, these numbers are expected to increase substantially by 2020. 2 Unfortunately, about 1 in 5 patients are dissatisfied following TKA 3 and ∼20% of TKA patients report persistent pain following surgery. 4 Dissatisfaction following TKA is associated with both knee-related pain and dysfunction. 3, [5] [6] [7] Further, dissatisfaction at 3-months post-TKA predicts minimal improvement or worsening outcomes 12-months post-TKA. 6 Increased understanding of the longitudinal postoperative course following TKA could result in better understanding of how some patients develop poor long-term outcomes. Six weeks after surgery, when intensive physical therapy rehabilitation has been completed, improvements in pain can be detected. 8 Further, the first 6 weeks post-TKA is an important period of time during which, for most patients, pain decreases while functioning and quality of life increase. By 6 weeks post-TKA, quality of life is similar to that before surgery, suggesting that the acute impact of surgery has leveled out by this point in time for most patients. 9 As initial improvement is expected by 6-weeks post-TKA, this may be an opportune time to assess for early indicators of longer-term outcomes.
We examined the course of pain and functioning between 6 weeks and 6 months post-TKA and examined relationships between demographic and clinical variables (at 6 wk post-TKA) and change in pain and function between 6-weeks and 6-months post-TKA. This study aimed to answer the following research questions: (1) how do levels of pain and functioning change between 6 weeks and 6 weeks post-TKA? and (2) what are the relationships between 6 weeks changes in pain and function between 6 weeks and 6 months and relevant demographic and clinical variables?
METHODS

Design
This study used a longitudinal design. Participants were initially recruited before TKA as part of a large randomized control trial of transcutaneous electrical nerve stimulation (TENS) efficacy following TKA (TANK study 10 ). Sample size was calculated based on the parent study 10 ; the current study provides a secondary analysis (which is appropriately powered for the statistics utilized). Data were collected preoperatively (demographics), at 6-weeks and 6-months post-TKA as part of the randomized control trial. This study was approved by the local Institutional Review Board and participants completed informed consent procedures.
Participants
Participants were English-speaking patients, aged 30 years or older, with OA who received unilateral TKA and provided data preoperatively and at 6-weeks and 6-months post-TKA. Exclusion criteria included: stroke/ central nervous system disease or mental illness, unable to understand tests/measures, receiving treatment for chronic pain other than knee OA, sensory impairment, permanently or indefinitely wheelchair bound, TENS use in the last 5 years, a condition that precluded TENS use, and current incarceration (for further details see Rakel et al 10 ).
Measures
Demographic and Medical Variables
Participants provided demographic information preoperatively including: sex, age, marital status, racial background, and education level. OA grade (Kellgren and Lawrence scale) was determined from the medical record.
Medication Use
Participants recorded postoperative opioid and nonopioid analgesic medication use. At 6 weeks postoperatively, participants provided doses of opioid and nonopioid medications taken the hour before assessment and at 6-months post-TKA, participants provided opioid and nonopioid medications and dosages taken per day.
Pain Intensity (Resting and Range of Motion [ROM]). Pain intensity was measured using a 21-point numeric rating scale (0 to 20 NRS) where 0 represents "no pain" and 20 represents "the most intense pain imaginable." The 21-point NRS was used based on data that it is comparable with the 0 to 10 scale, 11 and provides a greater range of possible responses that increases sensitivity to change and reduces tool failures (eg, circling 2 numbers or marking between numbers which is not interpretable accurately). The NRS was used to assess pain at rest and during active flexion and extension of the knee. Resting pain was assessed first, while participants were seated. Participants were given a laminated version of the pain scale to look at and asked to give a number that best described the intensity of pain they were experiencing. For pain during active extension of the knee, participants lay flat on an examination table with a rolled towel placed under the ankle of the surgical knee and straightened their leg as far as possible by pressing the knee down toward the examination table. Participants were asked to rate their pain during maximum extension while looking at the laminated pain scale. Pain during active flexion was assessed by participants bending their surgical knee as far as possible while keeping their foot flat on the examination table. Participants were asked to rate their pain during maximum flexion while looking at the laminated pain scale. ROM pain was determined by averaging their flexion and extension pain ratings. Participants were defined as having moderate to severe ROM pain of their surgical knee if their average ROM pain was between 8 to 20 on the 21-point scale (equivalent to 4 to 10 on a 0 to 10 scale, based on standard cut offs in the literature) and none-mild pain if their average ROM pain was between 0 to 7 on the 21-point scale. 12, 13 Function (Dysfunction). This was assessed using the Knee Injury and Osteoarthritis Outcome Score (KOOS), which is a self-report measure of knee-related problems. 14 The KOOS subscale: Function in Daily Living (KOOS ADL) was used to assess dysfunction. This KOOS ADL subscale has demonstrated good psychometric properties when used with patients with knee OA including internal consistency (α = 0.78 to 0.97) and reliability (interclass correlations = 0.84 to 0.94). 15 The KOOS has also demonstrated responsiveness in patients with knee OA following TKA. 16 Participants were defined as having moderate to severe dysfunction if their KOOS ADL Scale was <75. 17 Anxiety. This was assessed using the Trait scale of the State-Trait Anxiety Inventory (STAI). This scale has 20 statements, rated on a 4-point scale from "almost never" to almost always." 18 The Trait Anxiety scale assesses how participants respond to stressful stimuli in their environment. This widely used measure has strong psychometric properties 19 and it has been used in other studies of post-TKA patients. 20 Depression. This was assessed using the Geriatric Depression Scale. This measure is a 5-item depression screening tool; endorsing ≥ 2 items screens positive. This measure has demonstrated good interrater reliability (κ = 0.81 to 0.88), sensitivity (0.94 to 0.97), and specificity (0.81 to 0.85). 21, 22 Pain Catastrophizing. This was assessed with the Pain Catastrophizing Scale (PCS). 23 The PCS is a 13-item self-report measure that produces a total score and 3 subscale scores: Rumination (tendency to repetitively think of negative emotional experience), Magnification (effects of one's experiences are intensified), and Helplessness (passive submission to the painful stimuli). The PCS has good internal consistency (α = 0.87) and has been used to predict postsurgical pain. 24 Pain Sensitivity (Quantitative Sensory Testing)
Heat Pain Thresholds (HPT). HPTs were assessed using a computer-controlled TSA-II Neurosensory Analyzer (Medoc, Israel) and a Peltier thermode (size 16×16 mm). The thermode was placed against the participant's skin at 35°C, with the temperature rising 1°C/s to a maximum of 52°C. Participants pressed a button to indicate when the heat was first perceived as painful. HPTs were conducted on the surgical knee and contralateral tibia.
Pressure Pain Thresholds (PPT). PPTs were assessed using a hand-held pressure algometer (Somedic AB, Farsta, Sweden) with a 1 cm 2 probe applied at 40 kPa/S perpendicularly to the participant's skin. Participants pressed a button when the pressure was first perceived as painful (this was the PPT). PPTs were assessed on the surgical and contralateral tibia.
HPT and PPT measurements were performed on the surgical knee on 3 sites, using a standardized template for placement. The template was centered on the patellar midline incision. Three sites were identified 4 cm medial to the patellar midline incision, each site was 4 cm apart from one another, running in a line parallel to the patellar midline incision. The standardized template for the anterior tibialis muscle was placed on the tibial crest and 3 sites were marked 2 cm lateral to the tibial crest of the nonsurgical leg. The 3 sites ran vertically next to the tibial crest and were each 4 cm apart from one another. The average of the 3 scores was used as a final value for pain sensitivity at the surgical knee and tibia (see Rakel et al 10 for further details on how outliers were identified and averages determined). The pain sensitivity variables were included for examination in relation to pain severity.
Data Collection Protocol
Participants provided demographic data preoperatively. At 6-weeks and 6-months post-TKA, participants completed survey measures including report of opioid and other analgesic medication use, and were asked to rate their pain on a 0 to 20 NRS at rest (seated) and during active flexion and extension of the surgical knee, then a research assistant conducted the Quantitative Sensory Testing measures.
Data Analyses
All continuous variables were checked for normality and subsequent analyses chosen accordingly. Descriptive statistics for demographic, 6-weeks and 6-months post-TKA variables were presented as percentages for categorical variables, and mean ± SD or median (25th to 75th percentile) for continuous variables.
Research question 1 (how do levels of pain and functioning change between 6 wk and 6 mo post-TKA?) was investigated by determining the number of participants with no pain (NRS = 0), mild pain (NRS > 0 to 7), moderate pain (NRS > 7 to 14), and severe pain (NRS > 14) at 6-weeks and 6-months post-TKA and by determining the percentage of participants with none-mild dysfunction (KOOS ADLs ≥ 75) and those with moderate-severe dysfunction (KOOS ADLs < 75) at 6-weeks and 6-months post-TKA. The following change categories were calculated: improved (from moderate-severe pain or dysfunction at 6 weeks to none-mild pain or dysfunction at 6 mo), worsened (from none-mild pain or dysfunction at 6 wk to moderate-severe pain or dysfunction at 6 mo), remained stable/none-mild at both (none-mild pain or dysfunction at both timepoints), and remained stable/moderate-severe at both (moderate-severe pain or dysfunction at both timepoints). Percentages of participants who improved, remained stable, or worsened in pain and function between timepoints were then calculated.
For research question 2 (what are the relationships between changes in pain and function between 6 weeks and 6 months and relevant demographic and clinical variables?), continuous variables were calculated for change in pain and dysfunction. For pain, 6-months ROM pain was subtracted from 6-weeks ROM pain and for dysfunction, 6-weeks dysfunction was subtracted from 6-months dysfunction. As such, positive change scores for both pain and dysfunction indicted improvement. Univariate analyses were calculated between the demographic and 6-weeks clinical variables and the change variables (pain and dysfunction). All analyses assessing demographic and 6-weeks clinical variables associated with change in pain, adjusted for 6-weeks ROM pain and parallel analyses for change in dysfunction, adjusted for 6-weeks dysfunction. Correlations and Analysis of Covariance were used depending on the type of data. Variables that were significant in univariate analyses at P < 0.05, were entered into multivariate linear regression analyses. Separate models were run for change in pain and for change in functioning, controlling for 6-weeks pain and 6-weeks functioning (respectively).
RESULTS
A total of 223 participants completed measures preoperatively, 6-weeks and 6-months post-TKA. At both postoperative timepoints, some participants had missing data on specific measures; these participants were maintained in the study and simply excluded from the analyses for which that variable was missing (see Table 1 for the n of each measure). The mean age of the sample was 62 years (SD = 9.2), the sample was 56% female, 69% were married or cohabiting, and the mean body mass index was 34. for the surgical knee and 43.95 (SD = 2.78) for the contralateral tibia. At 6-months post-TKA, 16% of the sample had moderate to severe ROM pain (as reported previously 13 ), 23% of the sample had moderate to severe dysfunction (< 75 on KOOS ADLs), and 10% of the sample had both moderate to severe ROM pain and dysfunction.
Research Question 1: Pain Change Across Timepoints
Between 6-weeks and 6-months post-TKA, 75% of the sample stayed in the same pain category (64% reported 
(23%) (n = 212)
Where no n is indicated it is equal to 223. HPT indicates heat pain threshold; IQR, interquartile range; PPT, pressure pain threshold; TKA, total knee arthroplasty. none-mild pain at both timepoints and 11% reported moderate to severe pain at both timepoints), 20% improved, and 5% worsened. See Table 2 for variability within each change category and Figure 1 for changes across time between no pain, mild, moderate, and severe pain categories.
Function Change Across Timepoints
Between 6 weeks and 6 months, 65% of the sample stayed in the same category: 47% reported none-mild dysfunction at both timepoints ( ≥ 75 on KOOS ADLs) and 18% reported moderate-severe dysfunction at both timepoints (< 75 on KOOS ADLs). A further 30% improved (moving from moderate-severe dysfunction, to none-mild dysfunction) and 5% worsened (moving from none-mild dysfunction to moderate-severe dysfunction categories) between 6-weeks and 6-months post-TKA (see Table 2 and Fig. 2 ).
Research Question 2
Variables Associated With Change in Pain Between 6-weeks and 6-months Post-TKA Univariate analyses identified that 6-weeks anxiety (r = −0.20, P < 0.05) and 6-weeks pain catastrophizing (r = −0.24, P < 0.05) were significantly associated with change in pain when adjusting for 6-weeks ROM pain. See Table 3 for further details on all nonsignificant findings.
A multiple linear regression model controlling for 6-weeks ROM pain, found that both 6-weeks anxiety and pain catastrophizing each accounted for a significant amount of unique variance in change in pain (between 6 wk and 6 mo). The full model was significant: F 3,183 = 38.81, P < 0.05, adjusted R 2 = 0.38 (see Table 4 for individual beta weights). Of note however, the first step (including only 6 wk ROM pain) produced an adjusted R 2 = 0.32, indicating that Severe pain (n = 0) # of participants Pain at 6 months Severe pain at 6 weeks (n = 6) the addition of both anxiety and pain catastrophizing to the model only accounted for an additional 6% of variance. Overall, findings indicate that higher levels of anxiety and pain catastrophizing were associated with less improvement and that higher levels of 6-weeks ROM pain severity were associated with greater improvement (this was likely an artifact of a greater possible range of change scores available to those with higher pain at 6 wk post-TKA and the previously discussed findings that fewer participants worsened during this time period then improved).
Variables Associated With Change in Dysfunction Between 6-weeks and 6-months Post-TKA When adjusting for 6-weeks dysfunction, univariate analyses identified that the following variables were significantly associated with change in dysfunction between 6 weeks and 6 months: sex (F = 32.64, P < 0.05), depression screen (F = 19.48, P < 0.05), anxiety (r = −0.22, P < 0.05), and pain catastrophizing (r = −0.31, P < 0.05). See Table 3 for further details on all nonsignificant findings.
A multiple linear regression model controlling for 6-weeks dysfunction, found that sex, depression, and pain catastrophizing, but not anxiety, each accounted for a significant amount of unique variance in change in dysfunction (between 6 wk and 6 mo). The full model was significant: F 5,204 = 16.28, P < 0.05, adjusted R 2 = 0.27 (see Table 5 for individual beta weights). The first step (including only 6 wk dysfunction) produced an adjusted R 2 = 0.13, so the additional variables in the second step accounted for an additional 14% of the variance in change in dysfunction. Overall, findings indicate that male sex (mean change for males = 5.13, SD = 17.00; mean change for females = 10.69, SD = 12.40), higher levels of pain catastrophizing, and positive depression screen (mean change for positive depression screen = 2.70, SD = 24.85 and for negative screen = 9.23, SD = 12.06) were associated with less functional improvement. Further, higher 6-weeks dysfunction was associated with greater improvement, which was likely an artifact of a greater possible range of change scores available to those with higher dysfunction at 6-weeks post-TKA.
DISCUSSION
This study examined the longitudinal postoperative course following TKA. Findings suggest that the majority of patients' pain remained relatively stable from 6-weeks post-TKA to 6-months post-TKA, suggesting that 6-weeks post-TKA is an opportune timepoint to assess for early indicators of chronic pain. There is still, however, a significant subset (20%) of patients whose pain continued to improve after 6-weeks post-TKA. The current study helps identify these patients, suggesting that higher anxiety and pain catastrophizing 6-weeks post-TKA is associated with less improvement in pain by 6-months post-TKA. This is consistent with previous findings that preoperative anxiety and pain catastrophizing predict postoperative pain severity. 4, 13, 25, 26 Function appeared to be somewhat more variable then pain from 6-weeks post-TKA, with nearly one third (31%) of the sample continuing to improve by 6-months post-TKA. This fits with previous findings which suggest that functioning can continue to improve for at least 2 years post-TKA. 27 Multiple variables were identified that impact the trajectory of change in functioning between 6-weeks and 6-months post-TKA. Male sex, pain catastrophizing, and positive depression screen were significantly related to less improvement. These findings fit with previous findings that preoperative depression is associated with less functional improvement 2-years post-TKA 28 and lower function scores 5-years post-TKA. 29 This is also consistent with findings that greater preoperative pain catastrophizing is associated with worse functional outcomes 6-weeks post-TKA. 30 Male sex as a risk factor for dysfunction fits with Kauppila et al's 31 finding that males had smaller improvements in function compared to females following TKA. However, previous research has also identified female sex as a risk factor for persistent post-TKA pain. 25, 32 This discrepancy emphasizes the importance of investigating how variables relate differently to pain and functional outcomes following TKA.
The current study did not find pain sensitivity related to pain change trajectories between 6-weeks and 6-months post-TKA. Although recent pain sensitivity literature has identified that measures of central sensitization (widespread hyperalgesia and temporal summation) impact postoperative outcomes, 33, 34 the current study suggests that pain sensitivity (local and widespread hyperalgesia) 6-weeks post-TKA does not relate to changes in pain between 6-weeks and 6-months post-TKA.
This study was not without limitations. The sample was primarily Caucasian, which may limit the generalizability of findings. 35 In addition, the measure of depression utilized was a screen rather than a full diagnostic assessment. Finally, larger samples are needed to disentangle whether the same variables impact improvement compared to worsening during this postoperative time period.
In conclusion, the current findings suggest that the majority of patients stay in the same pain and functioning categories between 6-weeks and 6-months post-TKA; however, a notable subset continued to improve while only a few participants worsened in this timeframe. Further, with the exception of pain catastrophizing, different variables were associated with change in pain then were associated with change in functioning. Variables and Steps β P
Step 1 Dysfunction −0.37* 0.00 F 1,208 = 32.38, P = 0.00, Adjusted R 2 = 0. 
